BAT CDC Documents
Compapison of the Tumorigenic Activities of Janus Condensates Bo B2 and B4
Fields
- Original File
- BATCO002
- URL
- http://outside.cdc.gov/images4/00/02/49/70/doc00001.TIF
- Company
- British American Tobacco
- Date Loaded
- 04 Mar 2003
- Author
- WILKES EB
- Box
- B3310-6
Document Images
& COM~A~KSON OF THE TUMORIGENTC ACTIVITIES
OF JANUS CONDENSAIES BO, B2 AND BA
EEPOKT NO. RD.1537 RESTRICTED
24.10.1977
AUTHOR: E.B. Wilkes
ZSSUED BY: N.E. Willis
PROG. ~. :
D ZSTRIBUTTON:
Dr. S.J. Green Copy No. I
Dr. D.G. FalCon " " 2, 3
~ibrar7 " " 4, 5
COPY NO.:
mmma~
CO
mam~
BAT Co LTD - MINNESOTA TOBACCO LITIGATION

~-sWtC,~/461>-Z
Group Eeee•rch & Development Centre,
British-American Tobacco Co. Ltd.,
S0~N.
24ch October 1977
A COMPARISON OF THE TUMORIGENIC ACTZVITIES
OF JANUS CONDENSATES BO, B2~ AND BA.
(Report No. RD.1537 Restricted)
SLaY
This report describes a re-analysis o£ the early JANUS txpe~nts.
The &nalysis o£ the ¢•l£br&C£on groups seems to suggest that there was
e siKni£icanc loss of sensitivlty o£ the experimental animals during
the course of experiments BO to BS. This apparent effect could however
be due to • loss of act£vity of the standard carcinogens during storage.
This latter conclusion v•s supported by the results from Ohm J~NUS
repeat experiment B5 wh£ch showed no £all in the eati~stas o£ the
tumoriKeni¢ actlvlCy o£ the condeusetes which were re--exmLLned.
On this basle results £or condensate obtained from a cased and
£1avoured U.S. blend (B2) are compared with those from a £1ue-cured
all-lam£na bland (BO) and • lamina-stma blend (34).
Some of the data from the N.C.I. series Ill experiment has •leo
been rra~alymed. The results of this re-analysl8, combined with the
results £rom the JANUS ezperimenc8, lead to the concLusLon that there
ks no raison to belleve thac the incorporation of cocoa into the blend
of a c~sareCce leads to an Lucruse in the cumorilmn£c activity of the
smoke condensate. ~t is also concluded that the use of susar and/or
humeccant has no ef£ecc on tumorigenic accivitT.
I
mmm=h
BAT Co LTD - MINNESOTA TOBACCO LITIGATION

-2-
I. ENTRODUCTION
This comparison has been made in an attempt to assess more fully
the implications arising from some of the conclusions drawn from the
analysis of the Series ZIZ N.C.Z. 8kln palnting experiment (I).
2. THE DESIGN OF THE EXPERIMENTS
The comparison of these condensaCee is hampered by the fact that
they were not directly compared in 8 81nEle experiment, nor was a control
condensate used to fom a link between successive experiments in the JANUS
series. The relationship between these condensatee must be determined
by =onsiderinE the results obtained from the calibration groups, and the
results from experiment B5 wherein condensates BO and B2 were directly
compared, but only at a single dose level.
~n the early JANUS experiments (BO to B4) calibration groups of
animals were used. In each experiment there were & calibration groups
treated as follows:
The first calibration group was painted three times per week ~th
O. 1 mZ of palncin8 solution contelninE 20 ~K of 3,4-benzpyrene. This
painting continued throughout the first 13 weeks of che experiment
and then ceased.
2. The second group was similarly treated except that the painting
~onc£nued throughout the first 26 weeks o~ the experiment.
3. For the thLrd calibration group the O. 1 ml of paint4n8 solution
solution conta/~ed 20 ~g of 1,2, S,6-dibmnzanthracenm and the palntinS
was continued Chroushout the first 13 weeks of the experiment.
h. The fourth calibration group was slmilmrly crested to the third
except chat the paintinE continued throushout the first 26 weeks
of the experiment.
m
r~
Go
r~D
o
BAT Co LTD - MINNESOTA TOBACCO LITIGATION

-3-
Iu Kouer81, each of these Kroups contained 27 animals, but any
an/J~al dying durinK the £irst ~ weeks of the experLmont va8 replaced
whenever possible, 8o that the number of animals entering the experiJnent
is occasionally KreaCer than 27.
THE RESULTS FROM CALZBRATXON CROUPS BO TO B4
The data are eho~ Ln Tables 1 to 20. Experiments BA and BS
shared a common batch of animals and so only one set of ¢allbrat£on
Stoups was used for those two experiments. Zn Tables 1 co 20, T is
the experlme~c t£me £n weeks, N £8 the number of annuals as risk oc
she beginn£ng o£ the time period, D£ £s the number of animals respo~d£ns
during the time period (£.e. the number o£ animals becom£nK t,m~ur-baaring,
or the number o£ animals becoming malignant cumou~-bear£nK) and D2 Is the
number of animals dyin8 vithouc respondins.
Since the animals used in these calibration Kroup8 ~ere not painted
th~ouKhout their Lifetime the simple Weibull model i8 noC appropriate
for the enelys£8 of th48 data. A6e stsndardismt£0u procedures were
therefore used So obca£n t~nour rases corrected for mor~l~cy end these
aKe-scandardised turnout rates are shown in Table 21. The ase-scandardlaatlon
procedures used (Lee actuarlal method) £8 described in (2). The 8~andard
aKe-speclfic mortallcy rates used are shown in Table 22.
The aSe-standardlsed turnout rates of these callbrat£on Stoups are
8hou~ plotted 4n Y£Suro8 1 to 4 and from chase jraph8 £t 48 clear that
not onl7 £s the response to the two carcinoKens different, and that
the duret£on o£ treatment has on of£oct on response, but also that there
ha8 been a £a11-o££ in the response of the exper£mmntm2 an~T.ma18 to
those standard carcinosens. The analys£e of var£ance shown in Table8 23
w
w
BAT Co LTD - MINNESOTA TOBACCO LITIGATION

-4-
and 74 confirm this visual assessment of the data. The between carcinogen
effect and the between duration effect ere both highly sisnifican~, and
there is no siEnlficant carcinogen x duration interaction. The ~inear
time trend is hiEhly siK~/ficant, and for the all turnout data there is
some evidence of a norr-llne&r component in thR time trend.
The coefficients for Time (linear) in the model used were, for
ell tumours -.05781, end for meliEnant tumours -.04271. For the
purposes of fittinK the s~del the starting times for Bl, B2, B3, and
BA were measu=ed £n days after the start time for BO. Since the arc sin
square root transformation was .sea (to homoEenise the variances) these
coefficients are in units of sin-I 4response rate per day, the response
race beinK expressed as • fraction of unity rather than as a percentaEe.
The fitted lines are also drawn on FiEures I to 4.
This analysis of the calibration Eroups indicates that for the
early JANUS experiments, successive batches of animals showed a
diminishing response to the standard carcinogens benzpyrene and dibeu-
anthracene applied to the shaved dorsal skin of the animals. For the
experiments studied (BO to B4) this fall-off in response 18 l£~,aar with
t~na, after the arc Sin square root varienc@ s~tb£1~s£nK transformation
has been used.
THE KESULTS FROM CONDENSATE TRY.ATED GROUPS BO TO B5
The data are shown in Tables 25 to 39, and the eKe--sr~sndmrdf.sed
ttmour rates ere shown in Table 40. (JANUS experiment B1 is omitted
since the puff volumes were varied durinK condensate production. The
BI condensates are therefore not directly comparable with those of
other experiments. )
rag.rob
CO
r~
BAT Co LTD - MINNESOTA TOBACCO LITIGATION

-5-
Figures 5 and 6 show plots of the aKe-standmrdised turnout rates
of the reported experiments. These were"
(a) BO, dose level 50 ms, repeaeed in BS.
(b) B2, dose level 50 ms, repeated in BS.
(c) B3, dose level 50 ms, repeated in BS.
From these figures it £s apparent that there has been no faLl-off in
the response of the animals towards the smoke conden~ates.
Thus we are left with ~ contradictory observetlons. On the one hand
the calibration Kroups show 8 clear 1o8s of response of the 8signals towards
the standard carclnosens benzpyrene and dlbenzanthracene, but on the ocher
hand the response to the condensates BO, B2 and B3 has not chnged.
In (3) the fall in response of the calibraClon groups was noted,
and it was concluded that the activity of the standard carcinogens had
fallen i.e. under the conditions of storage being used, the dibmzzan~hracmnm
and the benzpyrene (kept both as solid and £n solution) was deterlorandns.
Ocher, more complex, explanations of PiKures I to 6 are of course possible,
but £n the absence of supporting evldlnce for an alternative explanation
the m/~ple hypothesis of loss o£ mcCivIL-y of the scmnddrd chem~cmls
seems the most rmasouab~Le to adopt.
Figures 7 and 8 show the &Ke-scandardlsed turnout races of the four
coudeusaces SO, B2, B3 and B4 plotted against dose level. From chase
graphs it can he seen thac there ere d£fferences becwemn the condansaces,
and Chac the highest dose level used (75 ms three t£mss per reek) was
probably Coo high in Chat the "high dose anomaly" is displayed by all
four curves. That is Co say, the response eC the high~sC dose leve~ £s
less than ~uld be expected from :he responses observed at the two lower
dose ~LevelLs.
mmmlp
r~J
BAT Co LTD - MINNESOTA TOBACCO LITIGATION

The differences between the =ondensares were 8x~n~ned using the
Weibull distribution function. Using the methods described in (4),
c~n values of k and w, and separace values o£ b for each group of
animals, were E£tted to the data o£ Tables 25 to 39. Estates Og the
parameters were obtained for all tumours and for malignant tumours
only. The est~zates of b, k and w, vlth the associated 8~umry
stat£stLcs S and V, are shown in Tables A1 end 42.
The goodness-of-fit of these parameters to the t~nour 4ncldence
data was tested via the usual X2 s~atistic and the results are shown
in Tables A3 and 4A. The values of X2 obtaLned (9.630 for all t~mours,
7.1A3 for m=lignant turnouts, both with 6 degrees o£ freedom) are noc
significant at the 95X level of eonf£dence, indicating ti~l: a satLsfaeto~-y
££t has been achieved.
Tables 4S and A6 show the results of an analysis of var£enee
derived £roa the l£kel£hoods of var£ous We£bu11 models fitted to the
data. This technique £s gully described in (A). These a~alyses sho~
that the dif£erences bet~nan the coudensates are hilhl7 s£S~Lficant,
that the dose levels used have a h£Khly s~Knificant e£fect, and that
there is no siEn~ficant condensate x dose interact£on. The partitlon£ng
of the dose ef£ect shows ~hat bo~h the dose linear and dose non-l£near
terms are highly sLgn£flcant.
The tumorigen£e ratios show that all the pair-~rise di££eranees
bet~an the four condansatas (BO, B2, B3, BA) era significant, and that
the ranlo8 derLved from the all-t~our amalya£s are 4n good agreement
with those obta£ned from tho analTsis of maLiKr~nt turnouts. The
tumor£sen~e ratios are Lnterpreted as £ollovs. For ~le, the
rat£o for BO v. B2 (all turnouts) is 0.771. This means that a dose
m
BAT Co LTD --- MINNESOTA TOBA.CCQLITIC;ATION

-7-
imvel of iOO mg of condensate B2 would produce the same t~r£Ke~c
response in a group of animals as a dose o£ 77.1 ~ of condensate
BO (other dose levels pro race). This interpretation assumes thac
the dose-response relationship is ILnear over the range of doses
cons Ldmred.
Figure 9 however indicates thac there is some evidence of a high
dose anomaly. That is to may, the response of the animals at the
highest dose ~evel is somewhat less than expected a£tmr due allowance
h;Ls been made for the e££ects o£ morcallcy. The analysis of variance
shown in Tables A5 and A6 congirm the presence o£ thls anomaly in Che
sense that the dose non--llnear term is highly s4~flcamt. This non-
linearity o£ response will lead to a bias £n the estimate o£ the slope
o£ the dose-response line when the linear model is £itted to the data
tar the purposes o~ computLn~ the tumox~Kenic ratios. Thus a better
ear,mate o£ these ratios may be obtained by omitting the hiah dose
level data from the analysis.
The tumo:igenic =atios obtained by omitCin8 the 75 ms dose level
dace are shown in Table 47. A couwsr~son o£ Table 47 with Tables 45
and 46 shows that the e££act o£ omitting the h~gh dose level data Ls to
reduce the di££erences between the condensates i.e. the tumor4Kam£c
ratios have all become closer to 1.0. As a result, one of the comperiao~s,
B2 v. BA tar malignant turnouts, is no longer e£Sni£icanc at the 95Z
level o£ ccm~4dence. When considering di££erences between these
condenaates, the ratios og Table 47 are to be pra£et~red to those o£
Tables 45 and A6.
BAT Co LTD - MINNESOTA TOBACCO LITIGATION
........................................... ]

-8-
5. THE RESULTS FROM THE N.C.I. THIRD SERIES OF CIGARETTES
The data, taken from (I), are shown in Tables 48 co 57. It will
be noted from Tables 48 and 53 that groups 3 and 4, and Stoups 31 and
32, were all painted an Uhe low dose level (12.5 mE). In the analysis
that follows groups 3 and 4 were pooled to form e sinE'le group, as were
groups 31 and 32. Similarly, groups 7, 29, 51 and 53 are all repeats
of the control blend (SEB ~II with casing) at the low dose level and
8o were pooled to form a single group, and the group 8, 30, 52 and 54
were pooled to give • single high dose level (25 mE) group for the
control blend.
A X2 nest based upon likellhoods derived from Welbull parameters
shows ChaC this pooling is in general justified. There was some
indication chac the four low dose level groups for the control blend
were differing in response, group 51 being suspiciously low. (These
four groups were nonetheless combined to form a single group.)
The age-standardised t~ur rates are shown in Table 58. The
actuarial method due to Lee was used, and in order to minim/me the
corrections due Co the different mortelit£es of the various groups the
age-speciflc mortality races were derived from the mean mor~allty of
the groups being compazed. These age-specific mortality rates are
shown in Table 59. The data of Table 58 are shown plotted in Figure IO.
The conclusions drawn by N.C.I. are summarised 4. Table 60 (Oaken
from (1)), m~eompanied by Ohm followLng c~ents=
"SEB ITI rich powdered cocoa ranks 14tb out of ~he 19 va~£ables
eesced st the I2.5 ms dose Level and 19tb of the 23 variables tested
at the 25 ms dose level. These low rankln6s suggest than powdered cocoa
contributes co the tumorigenicity of the condensate.
t,,u
r~
CXD
BAT Co LTD -_MINNESO_ TA__TOBACCO LITIGATION

-9-
SEB lZZ with no sugar and SEB ZI~I with no hmnecCmnt bol:h have
about the same ranking as SEB $II at each dose level, ms&seating thst
sugar by itself or humectant by itself has little or no effect on
condensate tumorigenicity. On the ocher hand, SEB ~TI" ~Ch neither
sugar nor h,wnectant has a ranking comparable to SEB ZIZ at the 12.3 n~
level, but ranks let among all 23 variables tasted at t~e 25 mS level.
This suggests thac at the lower dome, sugar and humectanc in combination
have little effect on condensate tumorigenicity but, at the higher dose
level, sugar and humectaut in combi~acioa may contribute to condensate
tumoriKenicity."
Eeferr£ng to 7iKu~e ~0," these couclusions ms7 be summa=ised as:
B is more active chat C, E, Y or G.
C, E, ¥, and G are the same at the low dose level, but Y ks less
active than C, E, or G at the high dome level.
(~n passing, it must be noted that the 19 variables tasted at
the low dose levml, and the 23 tested at the high dome level, refmrced
to by H.C.Z., arm the full set of variables ezmninad in their experiment.
The data in Tables 48 to 57 are a subset of the data given 4n (I). This
subset forms the basis o£ the N.C.~. coucZusious rosardin8 the tumorigenic
activity of cocoa, sugar, and humectant. )
The N.C.I. conclusions glvm much weight to the low response of F
at the 25 mS doe level, and interpret Chls effect as some kind of
synergistic efface of 8user and h~mectant. I cannot accept these
conclusions because
(a) £t is difficult to i~agine a cumorigouic effect of sugar
and hummctant much that it is demonstrable at the 25 q dose
level but not at the 12.5 mS Level.
mmm.~
~D
C0
BAT Co LTD - MINN~TA TOBACCO LITIGATION
